NCT04523181 Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients Status COMPLETED Phase PHASE2
NCT04522089 A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine Status COMPLETED Phase PHASE1
NCT04521309 SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients Status COMPLETED Phase PHASE1/PHASE2
NCT04521088 Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic Status COMPLETED Phase N/A
NCT04519255 Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT Status UNKNOWN Phase N/A
NCT04519125 Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia Status UNKNOWN Phase PHASE2/PHASE3
NCT04516811 Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19 Status TERMINATED Phase PHASE3
NCT04516746 Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults Status COMPLETED Phase PHASE3
NCT04514627 Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19 Status COMPLETED Phase NA
NCT04514302 Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab')2 Fragments (INOSARS) for Adult Patients With Mild COVID-19 Status COMPLETED Phase PHASE1
NCT04512027 Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support. Status COMPLETED Phase NA